Dioxins, a class of environmental pollutants resulting from the production and combustion of chlorinated compounds, have been shown to cause cardiovascular toxicity in animals ([@b11-ehp-116-1443]; [@b20-ehp-116-1443]; Kopf et al. 2007; [@b29-ehp-116-1443]). Although a number of epidemiologic studies have examined the association of dioxin exposure with cardiovascular disease (CVD) morbidity or mortality, we found no published systematic reviews on this topic, possibly because dioxin epidemiology research has focused primarily on the association with various cancers \[[@b19-ehp-116-1443]; [@b34-ehp-116-1443]\]. In this review we focus on CVD mortality. Given the large worldwide burden of CVD, the potential role of dioxin exposure as a preventable risk factor could be of substantial public health and clinical interest, especially in the context of recent reports of elevated environmental dioxin levels in China ([@b26-ehp-116-1443]; [@b28-ehp-116-1443], [@b27-ehp-116-1443]) and ubiquitous low levels worldwide ([@b40-ehp-116-1443]).

Definition of "dioxin."
=======================

The term "dioxin" refers to a diverse group of structurally related, environmentally persistent chemicals that exert toxic effects through a common pathway mediated by the aryl hydrocarbon receptor ([@b48-ehp-116-1443], [@b49-ehp-116-1443]). Dioxins include several types of polyhalogenated aromatic hydrocarbons: polychlorinated dibenzofurans (PCDFs); some types of poly-chlorinated biphenyls (PCBs); and polychlorinated dibenzo-*p*-dioxins (PCDDs), including 2,3,7,8-tetrachlorodibenzo-*p*-dioxin (TCDD), the most potent member of this class of chemicals. Although "dioxin" is also sometimes used to refer to TCDD alone, in this review we use the broader definition.

Animal and laboratory evidence
==============================

Although studies have demonstrated that the fetal mammalian heart is a sensitive target of TCDD-induced teratogenicity ([@b43-ehp-116-1443]), only in the past few years have toxicologic studies demonstrated cardiovascular effects after exposure to dioxins in adult rats and mice. These effects did not seem to occur as a result of overt toxicity. Chronic exposure of rats to either TCDD or PCB-126, the most potent of the dioxin-like PCBs, led to a dose-dependent increased incidence of degenerative cardiovascular lesions, including cardiomyopathy and chronic active arteritis ([@b20-ehp-116-1443]). PCB-126 also increased heart weight, serum cholesterol levels, and blood pressure in rats ([@b29-ehp-116-1443]). Adult mice exposed subchronically to TCDD developed increased blood pressure and heart weight, as well as elevated markers of oxidative stress ([@b24-ehp-116-1443]). Increased blood pressure and triglyceride levels were also observed after an acute high dose of TCDD in mice ([@b11-ehp-116-1443]). *ApoE*−/− mice exposed to subchronic doses of TCDD also developed earlier and more severe atherosclerotic lesions ([@b11-ehp-116-1443]). Some of these changes may be due to altered gene expression, inflammation, and oxidative stress ([@b1-ehp-116-1443]; [@b30-ehp-116-1443]), whereas others may relate to direct affects on cardiomyocytes involving dioxin perturbation of key calcium signaling pathways leading to abnormal depolarization ([@b53-ehp-116-1443]). Recent evidence that TCDD causes mitochondrial dysfunction in cell culture ([@b6-ehp-116-1443]) may suggest an additional mechanism for the effect of dioxin on the cardiovascular system. Such molecular, physiologic, and morphologic effects in rodent models all provide biological plausibility to the association observed in epidemiologic studies between exposure to dioxins and CVD mortality.

Methods
=======

Search strategy and selection criteria
--------------------------------------

We found articles by searching PubMed ([@b35-ehp-116-1443]) in December 2007 using the keyword "mortality" in combination with each of the following: dioxin, TCDD, PCDD, PCDF, phenoxy, chlorophenoxy, chlorophenol, and trichlorophenol. From this initial list, we selected studies that reported original epidemiologic data on mortality, in English, from either all cases of CVD, or ischemic heart disease (IHD). Other subtypes of CVD mortality (e.g., hypertension) were inconsistently reported; therefore, we did not examine them in this review. [Figure 1](#f1-ehp-116-1443){ref-type="fig"} illustrates the study selection process.

We excluded studies with insufficient evidence of exposure to dioxin (e.g., ecologic studies, studies of Vietnam veterans not involved in herbicide spraying, or studies of pesticide applicators without information on which pesticides were used and whether dioxin contamination was possible). We also excluded studies whose primary exposure was to PCBs. Only 12 of 209 PCBs have dioxin-like activity, so exposure to non--dioxin-like PCBs would complicate the interpretation of any association of total PCBs with CVD.

Although dioxin exposure may occur during leather tanning and processing ([@b32-ehp-116-1443]) and in flavor and fragrance production ([@b44-ehp-116-1443]), we excluded studies of cohorts from these industries due to the multiple cardiotoxic coexposures involved, including methylmercury, arsenic, and xylene.

If several follow-up studies had been published for a cohort, we included only the most recent results. By necessity, we made an exception when applying this rule to the IARC multicenter cohort, which updated and pooled the results of 36 individual cohorts ([@b50-ehp-116-1443]). We did not include the earlier publications from these cohorts, as our protocol specified. The difficulty arose when four cohorts that were included in the IARC multicenter study subsequently published additional results: either additional follow-up time ([@b14-ehp-116-1443]; [@b42-ehp-116-1443]; [@b45-ehp-116-1443]), or identical follow-up time but with more detailed exposure assessments ([@b18-ehp-116-1443]). Because the new results from these studies provided additional information, but the older results could not be dissociated from the summary relative risks (RRs) of the IARC study, we had no alternative but to effectively include these four studies twice; once as components of the IARC results, and then again as updated individual publications. Because these study results are therefore not independent, we did not attempt to quantitatively combine the RRs in a meta-analysis.

Results
=======

Description of included studies
-------------------------------

Eleven cohorts ([@b2-ehp-116-1443]; [@b5-ehp-116-1443]; [@b14-ehp-116-1443], [@b15-ehp-116-1443]; [@b17-ehp-116-1443]; [@b18-ehp-116-1443]; [@b22-ehp-116-1443]; [@b37-ehp-116-1443]; [@b42-ehp-116-1443]; [@b45-ehp-116-1443]; [@b46-ehp-116-1443]; [@b50-ehp-116-1443]) remained after we applied the exclusion criteria to the 393 initial PubMed search results ([Figure 1](#f1-ehp-116-1443){ref-type="fig"}). We identified one additional cohort ([@b10-ehp-116-1443]) by searching the citations, for a total of 12 included cohorts. Ten involved occupational or military exposure to dioxins, whereas the other two were environmentally exposed ([@b5-ehp-116-1443]; [@b46-ehp-116-1443]). One study was a large, multicenter cohort study ([@b50-ehp-116-1443]) conducted by IARC, which examined noncancer mortality from 36 occupational cohorts and 26,976 workers potentially exposed to TCDD or other highly chlorinated dioxins. Of the 11 other cohorts, 4 were also part of the IARC study ([@b14-ehp-116-1443]; [@b18-ehp-116-1443]; [@b42-ehp-116-1443]; [@b45-ehp-116-1443]), but we still included them separately in this review because they subsequently published additional follow-up or more detailed analyses.

Although quantitative dioxin exposure profiles for each cohort were not available because limited biological measurements were performed, broad exposure categorizations are possible. The workers in the 10 occupational cohorts were primarily exposed to PCDDs through the production and/or application of phenoxy acid herbicides and chlorophenols ([@b50-ehp-116-1443]), with some possible PCDF exposure, as well ([@b4-ehp-116-1443]). Of the remaining two studies, the Italian Seveso population ([@b5-ehp-116-1443]) was acutely exposed to high levels of environmental TCDD contamination after an industrial accident, whereas the Taiwanese Yucheng population ([@b46-ehp-116-1443]) was acutely exposed to a mixture of PCDFs and PCBs from ingesting contaminated rice oil. The latter study was included in spite of the PCB coexposures, because the toxic effects have been suggested to correlate more closely with exposure to PCDFs ([@b39-ehp-116-1443]).

Criteria of study design quality
--------------------------------

We grouped study results according to two well-recognized criteria of study design quality. The first criterion was whether mortality among the exposed participants was compared with an internal or an external reference group. External comparisons used standardized mortality ratios (SMRs) to compare the number of deaths observed in the exposed group (e.g., dioxin-exposed factory workers) with the number of deaths expected in the general population, standardized for age and sex. The primary limitation of external comparisons is that whenever the exposed group is an employed population, associations between exposure and CVD mortality will be biased downward (generally below the null) because workers are healthier on average than the general population ([@b31-ehp-116-1443]) ("healthy worker effect"). Internal comparison studies instead contrast the highest-exposed groups with the lowest-exposed group in the study population, which minimizes the healthy worker effect bias if the cohort is occupational, as well as potential confounding by other factors that do not vary within the study population. For these reasons, internal comparisons are of higher quality than external comparisons.

The second criterion we used to evaluate studies in this review was exposure assessment quality. Many studies had little information on exposure level and therefore considered all members of the exposed group to be equally exposed. Because of these crude exposure estimates, the exposed groups may have contained individuals with low or no actual exposure. This nondifferential misclassification would tend to dilute any associations between exposure and CVD mortality, biasing the associations downward. In contrast, some studies were able to conduct more detailed exposure assessments, using exposure measures that varied in complexity from dichotomous yes/no exposure among workers (IARC), to septiles of cumulative exposure \[National Institute for Occupational Safety and Health (NIOSH)\]. Additional details on these studies' personal exposure assessments can be found in the original articles ([@b5-ehp-116-1443]; [@b14-ehp-116-1443]; [@b18-ehp-116-1443]; [@b22-ehp-116-1443]; [@b37-ehp-116-1443]; [@b42-ehp-116-1443]; [@b50-ehp-116-1443]).

Crude exposure assessments, with either internal or external comparisons
------------------------------------------------------------------------

[Table 1](#t1-ehp-116-1443){ref-type="table"} presents the results of analyses using the crudest exposure assessments (i.e., only exposed vs. unexposed), with either internal or external comparisons. Most external comparison studies in this group found no elevated SMRs for either IHD or all CVD. This included the Seveso ([@b5-ehp-116-1443]) and Yucheng ([@b46-ehp-116-1443]) studies, even though no healthy worker effect bias was present because the exposed were part of the general population. Of the two internal comparison studies, the Ranch Hand study ([@b22-ehp-116-1443]) showed a modestly elevated RR for all CVD (RR = 1.3; *p* = 0.07), whereas the Army Chemical Corps study ([@b10-ehp-116-1443]) did not show an increased risk (RR = 1.06; 0.62--1.82).

Detailed exposure assessments, with external comparisons
--------------------------------------------------------

Four studies conducted external comparisons but stratified their SMRs by detailed exposure level ([@b5-ehp-116-1443]; [@b37-ehp-116-1443]; [@b42-ehp-116-1443]; [@b50-ehp-116-1443]). Because external comparisons were used in these studies, healthy worker effect bias may be present in the three studies in which the exposed group had occupational exposure ([@b37-ehp-116-1443]; [@b42-ehp-116-1443]; [@b50-ehp-116-1443]), but not in the fourth study (Seveso), in which the exposed group was environmentally exposed ([@b5-ehp-116-1443]). These results are not shown separately because three of the four studies also included internal comparisons ([Table 2](#t2-ehp-116-1443){ref-type="table"}) and found similar results.

In the Seveso study, [@b5-ehp-116-1443] calculated the SMRs in the highest and second-highest exposure zones. Exposure in this study was ecologically defined by proximity to the site of an industrial accident. The IHD SMRs \[95% confidence intervals (CIs)\] were 0.8 (0.4--1.5) and 1.0 (0.8--1.2), respectively, and were similar for all CVD. Although no trend was seen between the two highest-exposed zones at the 20-year follow-up, a significantly elevated RR for all circulatory disease was seen among the men in the highest-exposed zone, but only within 10 years of the accident (Consonni D, personal communication; data not shown), leading the authors to hypothesize that psychosocial stress was the cause ([@b5-ehp-116-1443]).

The IHD SMRs (95% CIs) for the IARC and NIOSH studies from lowest to highest exposure using the same categories as shown in [Table 2](#t2-ehp-116-1443){ref-type="table"}, were 0.85 (0.77--0.94) and 0.97 (0.90--1.04) for IARC ([@b50-ehp-116-1443]) and the SMRs were 0.93, 1.00, 1.05, 0.97, 1.10, 1.20, and 1.28 for NIOSH ([@b42-ehp-116-1443]) (no 95% CIs were shown; *p*-trend = 0.14). In the BASF study ([@b37-ehp-116-1443]), the IHD SMRs corresponding to the exposure categories of \< 0.1, 0.1--0.99, and ≥ 1 μg/kg TCDD body weight were 0.9 (0.3--1.8), 0.7 (0.2--1.7), and 0.6 (0.2--1.3), respectively. All of these results are qualitatively similar to the internal comparison results for each study.

Detailed exposure assessments, with internal comparisons
--------------------------------------------------------

[Table 2](#t2-ehp-116-1443){ref-type="table"} presents the results that we considered to be the highest quality according to our criteria, because the studies used both internal comparisons and more detailed exposure assessments. The data from [Table 2](#t2-ehp-116-1443){ref-type="table"} are shown graphically in [Figure 2](#f2-ehp-116-1443){ref-type="fig"} (IHD) and [Figure 3](#f3-ehp-116-1443){ref-type="fig"} (all CVD). Dose-related increases in IHD mortality were seen in all four studies reporting this outcome ([Table 2](#t2-ehp-116-1443){ref-type="table"}, [Figure 2](#f2-ehp-116-1443){ref-type="fig"}). *p*-Values for trend were calculated in the NIOSH ([@b42-ehp-116-1443]) and Hamburg ([@b14-ehp-116-1443]) studies and were *p* = 0.05 and *p* = 0.03, respectively. The RR in the highest exposure group was significantly elevated in the IARC ([@b50-ehp-116-1443]), NIOSH ([@b42-ehp-116-1443]), and Dutch ([@b18-ehp-116-1443]) studies.

For all-CVD mortality, the dose-related increases in mortality were less clear than for IHD ([Table 2](#t2-ehp-116-1443){ref-type="table"}, [Figure 3](#f3-ehp-116-1443){ref-type="fig"}). *p*-Values for trend given for the Ranch Hand ([@b22-ehp-116-1443]) and Hamburg ([@b14-ehp-116-1443]) studies were *p* = 0.07 and *p* = 0.05, respectively. The RR for all-CVD mortality in the highest exposure group was significantly elevated in the IARC study ([@b50-ehp-116-1443]), but not in the others. The BASF study ([@b37-ehp-116-1443]) found no association of dioxin with all CVD.

A major concern in all the reviewed studies was potential confounding by the major risk factors for CVD (e.g., diet, smoking, physical activity). If these risk factors were strongly associated with dioxin exposure, they could confound the association between dioxins and CVD, biasing it either upward or downward. Of the studies in [Table 2](#t2-ehp-116-1443){ref-type="table"}, only the Ranch Hand ([@b22-ehp-116-1443]) and BASF ([@b37-ehp-116-1443]) studies adjusted for possible confounding by some of the major risk factors for CVD \[smoking and family history of heart disease in Ranch Hand; smoking and body mass index (BMI) in BASF\]. The Ranch Hand study found moderately elevated adjusted RRs for all CVD (*p* for trend = 0.07). The BASF study found no elevated adjusted RRs for all CVD. Neither study examined IHD, and neither study presented crude RRs, which otherwise could have been compared with the adjusted RRs to assess the strength of confounding.

The Hamburg study ([@b14-ehp-116-1443]) reported stronger trends using estimated total I-TEQ \[toxic equivalencies of each dioxin relative to TCDD ([@b36-ehp-116-1443])\] than using only estimated TCDD concentration (data not shown). The TEQ results, which represent the cumulative potency of the multiple dioxin congeners, are considered more biologically relevant than using TCDD alone. The Hamburg study was the only study to use both measures.

Discussion
==========

The present review synthesizes the epidemiologic studies of dioxin and CVD mortality and advances our understanding by considering in detail the studies according to their quality. Studies using external comparisons and crude exposure estimates found no association between dioxin exposure and increased risk of IHD or all-CVD mortality, but this may be due to healthy worker effect bias ([@b31-ehp-116-1443]; [@b33-ehp-116-1443]; [@b51-ehp-116-1443]) and nondifferential misclassification of exposure. In contrast, the higher-quality studies using internal comparisons and detailed exposure assessments found a consistent association between dioxin exposure and increased risk of IHD mortality, and a relatively weaker association between dioxin exposure and risk of all-CVD mortality. However, only two of these studies adjusted for possible confounding by some of the major risk factors for CVD. Additionally, it is not possible to determine from the published data whether the association between dioxin exposure and all CVD would persist if we excluded IHD cases.

The Seveso study ([@b5-ehp-116-1443]) was the only large study to report no exposure--response increase in CVD mortality, despite stratification of the exposed into low and high categories, both of which were compared with an external referent group. Although the reason for the different results is unknown, the Seveso study differs from the other studies in several important respects. The Seveso study population had a younger age structure, and the TCDD exposure due to an industrial accident was acute and was assessed ecologically. Whether these factors partially account for the different results is unknown.

Limitations
-----------

The major limitation of these epidemiologic studies is the lack of adjustment for other major risk factors for CVD (including smoking, lack of physical activity, poor diet, and alcohol consumption). Only age was consistently adjusted for. The Ranch Hand ([@b22-ehp-116-1443]) and BASF ([@b37-ehp-116-1443]) studies adjusted for some of the potential risk factors for CVD, but because the crude RRs were not shown, the magnitude of confounding could not be assessed. Several authors have suggested that potential confounders in occupational mortality studies are unlikely to be sufficiently highly correlated with both the exposure and the outcome to completely explain a positive association of the magnitude seen here ([@b7-ehp-116-1443]; [@b25-ehp-116-1443]; [@b41-ehp-116-1443]). However, the possibility that the associations are affected by uncontrolled confounding cannot be excluded.

Some recent cross-sectional studies of dioxin exposure and CVD morbidity have found associations that persisted after more thorough adjustment for confounding ([@b16-ehp-116-1443]; [@b21-ehp-116-1443]; [@b23-ehp-116-1443]). [@b16-ehp-116-1443] reported an association between PCDDs (but not PCDFs) and self-reported CVD in the 1999--2002 National Health and Nutrition Examination Study (NHANES). The adjusted odds ratios (ORs), by PCDD exposure quartile, in both sexes combined were 1.0 (reference category), 1.4, 1.7, and 1.9 (*p* for trend = 0.07) after adjustment for age, race, BMI, smoking, alcohol consumption, exercise, cholesterol, hypertension, and C-reactive protein. No crude ORs were shown. [@b21-ehp-116-1443], in a study of Army Chemical Corps Vietnam veterans, found that spraying phenoxy herbicides was associated with an OR (95% CI) for self-reported heart disease of 1.41 (1.06--1.89), adjusting for age, BMI, and regular smoking. However, other cross-sectional studies of cardiovascular morbidity have not found significant associations with dioxin exposure ([@b8-ehp-116-1443]), indicating that more research is needed. The human evidence relating dioxins to potential intermediate causes of CVD, such as serum lipids, is similarly mixed \[[@b47-ehp-116-1443]\].

The associations between dioxin exposure and increased risk of cardiovascular mortality were in study populations with dioxin levels substantially higher than U.S. general population levels ([@b13-ehp-116-1443]; [@b38-ehp-116-1443]). However, [@b16-ehp-116-1443], using NHANES data, found an association between dioxin exposure and increasing prevalence of heart disease at U.S. general population levels. Several of the occupational studies that we reviewed presented the RRs among workers with low-to-moderate exposure levels that could be relevant to the general population. Although the RRs at low dioxin levels were elevated in several studies, the CIs were wide and the exposure categories were too broad to draw firm conclusions. More research is needed to characterize the CVD risk of low-level exposures, both in animal and in human studies.

The RRs from internal comparisons across the various studies are similar, even though the mean exposure levels differ. However, in each case the highest exposed category consisted of individuals with estimated exposures of comparable magnitude ([Table 2](#t2-ehp-116-1443){ref-type="table"}). Therefore, the similar RRs seen in the highest-exposed group of each study may truly be due to similar exposures in this group. It is also worth noting that the CIs around each RR are very wide, indicating that, for example, the slightly larger RR seen in the highest exposure group of the Dutch study ([@b18-ehp-116-1443]) compared with the Hamburg study ([@b14-ehp-116-1443]) (RR = 2.3 vs. RR = 1.89) might only be the result of sampling variability because their 95% CIs overlap considerably (1.0--5.0 vs. 0.79--4.51). Additionally, the magnitude of an RR can be affected by uncontrolled confounding or by the background rate of CVD in the referent group, which are also likely to vary among studies.

Another weakness of the reviewed mortality studies is the difficulty of accurately retrospectively assessing personal exposure. However, this exposure misclassification is likely to be nondifferential with respect to CVD mortality, which would tend to decrease the observed associations in the highest exposure category ([@b7-ehp-116-1443]; [@b12-ehp-116-1443]).

Most studies reported results only for TCDD, and not total TEQ, which is considered more biologically relevant. In addition, dioxin exposure was usually accompanied by coexposure to other contaminants, whose precise composition varied within occupational settings, and between occupational and environmental settings. It is a limitation of epidemiologic studies that separating out the effect of any one specific contaminant is difficult, especially given the possibility of synergism or antagonism. The primary occupational coexposure was to chlorophenols and their derivatives, but the available toxicologic studies of chlorophenols do not suggest that they have toxic effects on the cardiovascular system \[[@b3-ehp-116-1443]\].

Our findings do not directly address the risks of dioxin exposure for females because none of the internal comparison studies included substantial numbers of women. In a general population morbidity study, [@b16-ehp-116-1443] found very similar effects for men and women. However, another recent study found associations between dioxin exposure and mortality from both chronic rheumatoid heart disease and hypertension in women but not in men, whereas the association between dioxin exposure and mortality from all circulatory diseases was stronger in men ([@b9-ehp-116-1443]). Of the four animals studies we noted above, three used female animals ([@b11-ehp-116-1443]; [@b20-ehp-116-1443]; [@b29-ehp-116-1443]) and one used males (Kopf et al. 2007), and all observed cardiovascular effects. The limited evidence suggests that both sexes are sensitive to the cardiovascular effects of dioxins, although the possibility of the type and severity of effects differing by sex cannot be excluded.

The downward bias of the SMRs of occupational studies due to the healthy worker effect complicates their interpretation. This bias is illustrated by the substantially stronger associations found using internal comparisons than using SMRs in the IARC ([@b50-ehp-116-1443]) and NIOSH ([@b42-ehp-116-1443]) studies, despite the same exposure categories being used for both analyses.

Although information on the mortality status of the participants was available at the time of the retrospective exposure assessment, this was unlikely to influence the estimation process in a way that might induce a relationship between the estimated dioxin exposure and CVD mortality because the *a priori* focus of these studies was cancer mortality.

These studies were also limited by their reliance on mortality and death certificate diagnoses. However, CVD mortality is likely to be diagnosed relatively accurately, and any errors would affect the precision but not the validity of the results. Virtually identical *International Classification of Diseases, Ninth Revision* ([@b52-ehp-116-1443]) codes were used to define IHD and all CVD in each study.

The IARC internal comparison results at least partially include the results from three of the other internal comparison studies ([@b14-ehp-116-1443]; [@b18-ehp-116-1443]; [@b42-ehp-116-1443]; described in "Methods" and in [Figures 2](#f2-ehp-116-1443){ref-type="fig"} and [3](#f3-ehp-116-1443){ref-type="fig"}). This raises the question of whether the associations reported in the IARC study might be solely due to its inclusion of these three studies. This seems unlikely, however, because the magnitude of the associations seen in the IARC study is similar to those seen in these three studies ([Table 2](#t2-ehp-116-1443){ref-type="table"}), even though they represent only approximately 25% of the total number of participants included in IARC.

Conclusions
===========

The results of this systematic review suggest that dioxin exposure is associated with increased risk of mortality from both IHD and all CVD, although more strongly with the former. Although biological plausibility is provided by animal studies, uncontrolled confounding by other risk factors for CVD cannot be ruled out as a contributor to the association.

We hope our results will stimulate further evaluation of CVD incidence and mortality in dioxin-exposed cohorts, especially using internal comparisons with detailed exposure assessments, and careful control for confounding. Future studies in both animals and humans should assess whether cardiovascular effects are present at environmentally relevant doses. Of additional interest would be analysis of whether the association between dioxin exposure and all CVD persists when IHD cases are excluded, as well as a pooled or meta-analysis of the internal comparison results in order to obtain a dose--response curve for dioxin and CVD.
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###### 

RRs (95% CIs) for mortality from IHD and all CVD from both internal and external comparisons with crude exposure assessments, in dioxin-exposed cohorts.

  Comparison type/cohort                                          No.      IHD                 All CVD             Reference
  --------------------------------------------------------------- -------- ------------------- ------------------- ---------------------
  External                                                                                                         
   Canadian sawmill[a](#tfn2-ehp-116-1443){ref-type="table-fn"}   23,829   NA                  0.74 (0.71--0.76)   [@b17-ehp-116-1443]
   Seveso                                                         6,745    1.00 (0.8--1.2)     1.00 (0.8--1.1)     [@b5-ehp-116-1443]
   NIOSH                                                          5,132    1.09 (1.00--1.20)   NA                  [@b42-ehp-116-1443]
   Finnish sprayers                                               1,909    0.94 (0.80--1.10)   NA                  [@b2-ehp-116-1443]
   Yucheng                                                        1,823    NA                  1.00 (0.8--1.3)     [@b46-ehp-116-1443]
   Hamburg                                                        1,177    0.97 (0.77--1.22)   1.06 (0.90--1.24)   [@b15-ehp-116-1443]
   New Zealand                                                                                                     
     Production                                                   813      1.04 (0.74--1.43)   0.96 (0.72--1.27)   [@b45-ehp-116-1443]
     Sprayers                                                     699      0.49 (0.31--0.75)   0.52 (0.36--0.73)   
   Dutch                                                          549      1.20 (0.8--1.6)     1.00 (0.8--1.4)     [@b18-ehp-116-1443]
   BASF                                                           243      0.70 (0.4--1.1)     0.80 (0.6--1.2)     [@b37-ehp-116-1443]
  Internal                                                                                                         
   Ranch Hand                                                     20,340   NA                  1.30 (1.0--1.6)     [@b22-ehp-116-1443]
   Army Chemical Corps                                            5,609    NA                  1.06 (0.62--1.82)   [@b10-ehp-116-1443]

NA, data not available.

Using an alternate method of estimating person-time, the SMR for all CVD was 1.14 (1.10--1.18).

###### 

RRs (95% CIs) for mortality from IHD and all CVD from internal comparisons, by dioxin exposure level.

  Study                                                                                                                No.      IHD                      All CVD
  -------------------------------------------------------------------------------------------------------------------- -------- ------------------------ ------------------------
  IARC ([@b50-ehp-116-1443]), TCDD/HCD exposure                                                                        21,384                            
   No                                                                                                                  7,553    1.00 (---)               1.00 (---)
   Yes                                                                                                                 13,831   1.67 (1.23--2.26)        1.51 (1.17--1.96)
  NIOSH[a](#tfn4-ehp-116-1443){ref-type="table-fn"} ([@b42-ehp-116-1443]), cumulative exposure                         3,538                             
   0 to \< 19                                                                                                          505      1.00 (---)               NA
   19 to \< 139                                                                                                        505      1.23 (0.75--2.00)        NA
   139 to \< 581                                                                                                       505      1.34 (0.83--2.18)        NA
   581 to \< 1,650                                                                                                     505      1.30 (0.79--2.13)        NA
   1,650 to \< 5,740                                                                                                   505      1.39 (0.86--2.24)        NA
   5,740 to \< 20,200                                                                                                  505      1.57 (0.96--2.56)        NA
   ≥20,200                                                                                                             505      1.75 (1.07--2.87)        NA
                                                                                                                                Trend *p*-value = 0.05   
  Ranch Hand[b](#tfn5-ehp-116-1443){ref-type="table-fn"} ([@b22-ehp-116-1443]), dioxin exposure category (ppt lipid)   2,452                             
   Comparison                                                                                                          1,436    NA                       1.00 (---)
   Background                                                                                                          442      NA                       0.80 (0.4--1.8)
   Low (32.2--117.4)                                                                                                   287      NA                       1.80 (0.9--3.5)
   High (117.9--4221.9)                                                                                                287      NA                       1.50 (0.7--3.3)
                                                                                                                                                         Trend *p*-value = 0.07
  Hamburg[c](#tfn6-ehp-116-1443){ref-type="table-fn"} ([@b14-ehp-116-1443]), total I-TEQ (ng/kg lipid)                 1,177                             
   1.19--39.5                                                                                                          471      1.00 (---)               1.00 (---)
   39.6--98.9                                                                                                          235      0.85 (0.41--1.75)        1.34 (0.85--2.13)
   99.0--278.5                                                                                                         235      0.86 (0.41--1.83)        1.18 (0.71--1.95)
   278.6--545.2                                                                                                        118      1.31 (0.57--3.00)        1.21 (0.66--2.25)
   545.3--4361.9                                                                                                       118      1.89 (0.79--4.51)        1.40 (0.71--2.76)
                                                                                                                                Trend *p*-value = 0.03   Trend *p*-value = 0.05
  Dutch[d](#tfn7-ehp-116-1443){ref-type="table-fn"} ([@b18-ehp-116-1443]), TCDD dose (ppt lipid)                       1,031                             
   Low (7.1)                                                                                                           530      1.00 (---)               1.00 (---)
   Medium (7.7--124.1)                                                                                                 259      1.50 (0.7--3.6)          1.50 (0.8--2.8)
   High (124.2--7307.5)                                                                                                242      2.30 (1.0--5.0)          1.50 (0.8--2.9)
  BASF[e](#tfn8-ehp-116-1443){ref-type="table-fn"} ([@b37-ehp-116-1443]), estimated TCDD dose                          243                               
   1 μg/kg increase                                                                                                             NA                       0.93 (0.70--1.24)

Abbreviations: HCD, higher chlorinated dioxins; NA, data not available.

The number for each exposure group was estimated by dividing the sample into septiles, as done by [@b42-ehp-116-1443]. The cumulative exposure measure is a relative ranking; the units cannot be interpreted as a specific dose of dioxin.

The serum dioxin levels were extrapolated back to the end of service in Vietnam. No extrapolated dioxin levels were presented for the comparison or background categories.

The number for each exposure group was estimated by combining the two lowest quintiles and halving the highest quintile, as done by [@b14-ehp-116-1443]. The serum dioxin levels were extrapolated back to the end of occupational exposure.

The serum dioxin levels were extrapolated back to the end of occupational exposure.

This study presented the RR for all CVD only for a 1-μg/kg increase in estimated TCDD dose.
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